Microglia as critical mediators linking perinatal immune stress to mental health trajectories

Microglia, the primary immune cells of the brain, are increasingly recognized as key regulators of healthy brain development. They do not just respond to threats; they actively sculpt neural circuits by pruning synapses and interacting with neurons. This review explores how early life adversity—specifically immune activation during pregnancy (maternal immune activation) or stress—can disturb these processes, potentially predisposing individuals to later mental health disorders.

Developmental challenges, such as exposure to bacterial toxins (e.g., LPS), viruses, or prenatal maternal stress, do not affect all brains the same way. The authors highlight that while some exposures cause immediate, robust changes in microglial number and shape, others act more like 'primers.' In these cases, microglia may appear normal under baseline conditions but exhibit exaggerated, dysfunctional responses to subsequent immune challenges later in life. This state of priming is linked to impaired synaptic pruning, leading to persistent changes in neural circuitry and behavior that span into adulthood.

Evidence from humans with autism spectrum disorder (ASD), major depressive disorder (MDD), and schizophrenia (SCZ) points to consistent microglial dysfunction. Post-mortem brain studies and transcriptomic analyses show that these disorders often feature increased microglial density, shifts in morphology toward an 'activated' state, and molecular signatures indicative of altered inflammatory and phagocytic pathways. The authors emphasize that these molecular changes often occur in the absence of traditional, gross inflammation, suggesting more nuanced, cell-specific malfunctions that are likely rooted in early life events.